Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens

While emerging evidence indicates that dendritic cells (DC) play a central role in the pathogenesis of multiple sclerosis (MS), their modulation with immunoregulatory agents provides prospect as disease-modifying therapy. Our observations reveal that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) treatment...

Full description

Saved in:
Bibliographic Details
Main Authors: Wai-Ping Lee, Barbara Willekens, Patrick Cras, Herman Goossens, Eva Martínez-Cáceres, Zwi N. Berneman, Nathalie Cools
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2016/5392623
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545438892294144
author Wai-Ping Lee
Barbara Willekens
Patrick Cras
Herman Goossens
Eva Martínez-Cáceres
Zwi N. Berneman
Nathalie Cools
author_facet Wai-Ping Lee
Barbara Willekens
Patrick Cras
Herman Goossens
Eva Martínez-Cáceres
Zwi N. Berneman
Nathalie Cools
author_sort Wai-Ping Lee
collection DOAJ
description While emerging evidence indicates that dendritic cells (DC) play a central role in the pathogenesis of multiple sclerosis (MS), their modulation with immunoregulatory agents provides prospect as disease-modifying therapy. Our observations reveal that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) treatment of monocyte-derived DC results in a semimature phenotype and anti-inflammatory cytokine profile as compared to conventional DC, in both healthy controls and MS patients. Importantly, 1,25(OH)2D3-treated DC induce T cell hyporesponsiveness, as demonstrated in an allogeneic mixed leukocyte reaction. Next, following a freeze-thaw cycle, 1,25(OH)2D3-treated immature DC could be recovered with a 78% yield and 75% viability. Cryopreservation did not affect the expression of membrane markers by 1,25(OH)2D3-treated DC nor their capacity to induce T cell hyporesponsiveness. In addition, the T cell hyporesponsiveness induced by 1,25(OH)2D3-treated DC is antigen-specific and robust since T cells retain their capacity to respond to an unrelated antigen and do not reactivate upon rechallenge with fully mature conventional DC, respectively. These observations underline the clinical potential of tolerogenic DC (tolDC) to correct the immunological imbalance in MS. Furthermore, the feasibility to cryopreserve highly potent tolDC will, ultimately, contribute to the large-scale production and the widely applicable use of tolDC.
format Article
id doaj-art-6264d69ec1d24dbdaa62bd9654ac28ea
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-6264d69ec1d24dbdaa62bd9654ac28ea2025-02-03T07:25:42ZengWileyJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/53926235392623Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived AntigensWai-Ping Lee0Barbara Willekens1Patrick Cras2Herman Goossens3Eva Martínez-Cáceres4Zwi N. Berneman5Nathalie Cools6Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, BelgiumDepartment of Neurology, Antwerp University Hospital, 2650 Edegem, BelgiumDepartment of Neurology, Antwerp University Hospital, 2650 Edegem, BelgiumLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, BelgiumDivision of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti and Department of Cell Biology, Physiology and Immunology, The Autonomous University of Barcelona, 08913 Bellaterra, SpainLaboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, BelgiumLaboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, BelgiumWhile emerging evidence indicates that dendritic cells (DC) play a central role in the pathogenesis of multiple sclerosis (MS), their modulation with immunoregulatory agents provides prospect as disease-modifying therapy. Our observations reveal that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) treatment of monocyte-derived DC results in a semimature phenotype and anti-inflammatory cytokine profile as compared to conventional DC, in both healthy controls and MS patients. Importantly, 1,25(OH)2D3-treated DC induce T cell hyporesponsiveness, as demonstrated in an allogeneic mixed leukocyte reaction. Next, following a freeze-thaw cycle, 1,25(OH)2D3-treated immature DC could be recovered with a 78% yield and 75% viability. Cryopreservation did not affect the expression of membrane markers by 1,25(OH)2D3-treated DC nor their capacity to induce T cell hyporesponsiveness. In addition, the T cell hyporesponsiveness induced by 1,25(OH)2D3-treated DC is antigen-specific and robust since T cells retain their capacity to respond to an unrelated antigen and do not reactivate upon rechallenge with fully mature conventional DC, respectively. These observations underline the clinical potential of tolerogenic DC (tolDC) to correct the immunological imbalance in MS. Furthermore, the feasibility to cryopreserve highly potent tolDC will, ultimately, contribute to the large-scale production and the widely applicable use of tolDC.http://dx.doi.org/10.1155/2016/5392623
spellingShingle Wai-Ping Lee
Barbara Willekens
Patrick Cras
Herman Goossens
Eva Martínez-Cáceres
Zwi N. Berneman
Nathalie Cools
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
Journal of Immunology Research
title Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
title_full Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
title_fullStr Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
title_full_unstemmed Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
title_short Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
title_sort immunomodulatory effects of 1 25 dihydroxyvitamin d3 on dendritic cells promote induction of t cell hyporesponsiveness to myelin derived antigens
url http://dx.doi.org/10.1155/2016/5392623
work_keys_str_mv AT waipinglee immunomodulatoryeffectsof125dihydroxyvitamind3ondendriticcellspromoteinductionoftcellhyporesponsivenesstomyelinderivedantigens
AT barbarawillekens immunomodulatoryeffectsof125dihydroxyvitamind3ondendriticcellspromoteinductionoftcellhyporesponsivenesstomyelinderivedantigens
AT patrickcras immunomodulatoryeffectsof125dihydroxyvitamind3ondendriticcellspromoteinductionoftcellhyporesponsivenesstomyelinderivedantigens
AT hermangoossens immunomodulatoryeffectsof125dihydroxyvitamind3ondendriticcellspromoteinductionoftcellhyporesponsivenesstomyelinderivedantigens
AT evamartinezcaceres immunomodulatoryeffectsof125dihydroxyvitamind3ondendriticcellspromoteinductionoftcellhyporesponsivenesstomyelinderivedantigens
AT zwinberneman immunomodulatoryeffectsof125dihydroxyvitamind3ondendriticcellspromoteinductionoftcellhyporesponsivenesstomyelinderivedantigens
AT nathaliecools immunomodulatoryeffectsof125dihydroxyvitamind3ondendriticcellspromoteinductionoftcellhyporesponsivenesstomyelinderivedantigens